ID
CASC

Integral Derivatives’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Integral Derivatives’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,733
Closed -$23K – 1224
2015
Q4 		$23K Buy
1,733
+66
+4% +$1.14K ﹤0.01% 1039
2015
Q3 		$27K Buy
+1,667
New +$34.2K ﹤0.01% 1050
2014
Q2 		– Sell
-4,967
Closed -$89K – 1597
2014
Q1 		$89K Buy
4,967
+1,517
+44% +$24.9K ﹤0.01% 1237
2013
Q4 		$36K Buy
+3,450
New +$38.6K ﹤0.01% 1440

Other funds holding CASC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return